HESI RN Pharmacology Proctored Exam – 2026/2027
Edition – Original HESI-Style Practice Q&A
SECTION I: PHARMACOKINETICS & PHARMACODYNAMICS
Question 1
A nurse is teaching a client about a newly prescribed medication. The client asks,
"What does it mean when the drug has a half-life of 8 hours?" Which response by
the nurse is most accurate?
A. "The medication will be completely eliminated from your body in 8 hours."
B. "It takes 8 hours for the medication to reach its peak effectiveness."
C. "It takes 8 hours for half of the medication to be eliminated from your body."
D. "The medication will remain in your body for 8 half-lives before it is fully
eliminated."
Correct Answer: C
Rationale: Drug half-life is the time required for the serum concentration of a
drug to decrease by 50%. It takes approximately 4–5 half-lives for a drug to be
considered eliminated from the body (about 94–97% eliminated). Option A is
incorrect because complete elimination takes multiple half-lives. Option B
confuses half-life with time to peak effect. Option D incorrectly describes
elimination timing.
Question 2
A nurse is reviewing the concept of pharmacodynamics with a nursing student.
Which statement by the student indicates a correct understanding?
A. "Pharmacodynamics is the study of how the body absorbs, distributes,
metabolizes, and excretes drugs."
B. "Pharmacodynamics describes the biochemical and physiologic effects of drugs
on the body and the mechanisms of drug action."
C. "Pharmacodynamics involves the movement of drugs across cell membranes to
reach target tissues."
,D. "Pharmacodynamics refers to the genetic variations that affect drug
metabolism."
Correct Answer: B
Rationale: Pharmacodynamics is the study of what the drug does to the body—
the biochemical and physiologic effects of drugs and their mechanisms of action
at receptor sites. Option A describes pharmacokinetics. Option C describes drug
distribution (part of pharmacokinetics). Option D describes pharmacogenomics.
Question 3
A client is prescribed a medication that is highly protein-bound. The nurse
understands that which factor may increase the risk of drug toxicity?
A. Decreased gastric pH
B. Increased renal excretion
C. Administration with another highly protein-bound drug
D. Administration on an empty stomach
Correct Answer: C
Rationale: Highly protein-bound drugs compete for binding sites on plasma
proteins. When two highly protein-bound drugs are administered together, they
compete for binding sites, resulting in increased free (unbound) drug levels and
increased risk of toxicity. Only the unbound (free) fraction of a drug is
pharmacologically active.
Question 4
A nurse is calculating a medication dose for a client with a history of liver disease.
The nurse recognizes that liver disease primarily affects which phase of
pharmacokinetics?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
,Correct Answer: C
Rationale: The liver is the primary site of drug metabolism (biotransformation).
Liver disease can impair the metabolism of many drugs, leading to drug
accumulation and toxicity. Absorption is primarily affected by GI factors;
distribution is affected by protein binding and blood flow; excretion is primarily a
renal function.
Question 5
A client is receiving an intravenous medication that has a narrow therapeutic
index. The nurse should prioritize which action?
A. Administer the medication as rapidly as possible
B. Monitor serum drug levels closely
C. Administer the medication with food
D. Double the dose if the client reports no effect
Correct Answer: B
Rationale: Drugs with a narrow therapeutic index have a small margin between
therapeutic and toxic doses. Close monitoring of serum drug levels is essential to
maintain levels within the therapeutic range and prevent toxicity. Rapid
administration could cause toxicity; administering with food may affect
absorption but is not the priority; doubling the dose without prescriber order is
unsafe.
Question 6
A nurse is teaching a client about a medication that is an agonist at beta-1
receptors. Which statement by the client indicates understanding?
A. "This medication will block the effects of adrenaline on my heart."
B. "This medication will activate receptors in my heart and increase my heart
rate."
C. "This medication will have no effect on my heart rate."
D. "This medication will work on receptors in my lungs."
, Correct Answer: B
Rationale: An agonist binds to and activates a receptor, producing a response.
Beta-1 receptors are primarily located in the heart; activation increases heart rate
and contractility. An antagonist blocks receptor activation. Beta-2 receptors are
primarily located in the lungs.
Question 7 (SATA)
A nurse is reviewing the pharmacokinetic phase of distribution. Which factors can
affect drug distribution? Select all that apply.
A. Blood flow to tissues
B. Plasma protein binding
C. Drug lipid solubility
D. pH of the urine
E. Tissue membrane permeability
Correct Answers: A, B, C, E
Rationale: Drug distribution is affected by blood flow to tissues (better perfusion
= more distribution), plasma protein binding (only unbound drug is active), lipid
solubility (lipid-soluble drugs cross membranes more easily), and tissue
membrane permeability. Urine pH affects excretion (renal elimination), not
distribution.
Question 8
A client is receiving a medication that is a prodrug. The nurse understands that a
prodrug:
A. Is active in its administered form
B. Requires biotransformation to become active
C. Is always administered intravenously
D. Has no therapeutic effect
Correct Answer: B
Edition – Original HESI-Style Practice Q&A
SECTION I: PHARMACOKINETICS & PHARMACODYNAMICS
Question 1
A nurse is teaching a client about a newly prescribed medication. The client asks,
"What does it mean when the drug has a half-life of 8 hours?" Which response by
the nurse is most accurate?
A. "The medication will be completely eliminated from your body in 8 hours."
B. "It takes 8 hours for the medication to reach its peak effectiveness."
C. "It takes 8 hours for half of the medication to be eliminated from your body."
D. "The medication will remain in your body for 8 half-lives before it is fully
eliminated."
Correct Answer: C
Rationale: Drug half-life is the time required for the serum concentration of a
drug to decrease by 50%. It takes approximately 4–5 half-lives for a drug to be
considered eliminated from the body (about 94–97% eliminated). Option A is
incorrect because complete elimination takes multiple half-lives. Option B
confuses half-life with time to peak effect. Option D incorrectly describes
elimination timing.
Question 2
A nurse is reviewing the concept of pharmacodynamics with a nursing student.
Which statement by the student indicates a correct understanding?
A. "Pharmacodynamics is the study of how the body absorbs, distributes,
metabolizes, and excretes drugs."
B. "Pharmacodynamics describes the biochemical and physiologic effects of drugs
on the body and the mechanisms of drug action."
C. "Pharmacodynamics involves the movement of drugs across cell membranes to
reach target tissues."
,D. "Pharmacodynamics refers to the genetic variations that affect drug
metabolism."
Correct Answer: B
Rationale: Pharmacodynamics is the study of what the drug does to the body—
the biochemical and physiologic effects of drugs and their mechanisms of action
at receptor sites. Option A describes pharmacokinetics. Option C describes drug
distribution (part of pharmacokinetics). Option D describes pharmacogenomics.
Question 3
A client is prescribed a medication that is highly protein-bound. The nurse
understands that which factor may increase the risk of drug toxicity?
A. Decreased gastric pH
B. Increased renal excretion
C. Administration with another highly protein-bound drug
D. Administration on an empty stomach
Correct Answer: C
Rationale: Highly protein-bound drugs compete for binding sites on plasma
proteins. When two highly protein-bound drugs are administered together, they
compete for binding sites, resulting in increased free (unbound) drug levels and
increased risk of toxicity. Only the unbound (free) fraction of a drug is
pharmacologically active.
Question 4
A nurse is calculating a medication dose for a client with a history of liver disease.
The nurse recognizes that liver disease primarily affects which phase of
pharmacokinetics?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
,Correct Answer: C
Rationale: The liver is the primary site of drug metabolism (biotransformation).
Liver disease can impair the metabolism of many drugs, leading to drug
accumulation and toxicity. Absorption is primarily affected by GI factors;
distribution is affected by protein binding and blood flow; excretion is primarily a
renal function.
Question 5
A client is receiving an intravenous medication that has a narrow therapeutic
index. The nurse should prioritize which action?
A. Administer the medication as rapidly as possible
B. Monitor serum drug levels closely
C. Administer the medication with food
D. Double the dose if the client reports no effect
Correct Answer: B
Rationale: Drugs with a narrow therapeutic index have a small margin between
therapeutic and toxic doses. Close monitoring of serum drug levels is essential to
maintain levels within the therapeutic range and prevent toxicity. Rapid
administration could cause toxicity; administering with food may affect
absorption but is not the priority; doubling the dose without prescriber order is
unsafe.
Question 6
A nurse is teaching a client about a medication that is an agonist at beta-1
receptors. Which statement by the client indicates understanding?
A. "This medication will block the effects of adrenaline on my heart."
B. "This medication will activate receptors in my heart and increase my heart
rate."
C. "This medication will have no effect on my heart rate."
D. "This medication will work on receptors in my lungs."
, Correct Answer: B
Rationale: An agonist binds to and activates a receptor, producing a response.
Beta-1 receptors are primarily located in the heart; activation increases heart rate
and contractility. An antagonist blocks receptor activation. Beta-2 receptors are
primarily located in the lungs.
Question 7 (SATA)
A nurse is reviewing the pharmacokinetic phase of distribution. Which factors can
affect drug distribution? Select all that apply.
A. Blood flow to tissues
B. Plasma protein binding
C. Drug lipid solubility
D. pH of the urine
E. Tissue membrane permeability
Correct Answers: A, B, C, E
Rationale: Drug distribution is affected by blood flow to tissues (better perfusion
= more distribution), plasma protein binding (only unbound drug is active), lipid
solubility (lipid-soluble drugs cross membranes more easily), and tissue
membrane permeability. Urine pH affects excretion (renal elimination), not
distribution.
Question 8
A client is receiving a medication that is a prodrug. The nurse understands that a
prodrug:
A. Is active in its administered form
B. Requires biotransformation to become active
C. Is always administered intravenously
D. Has no therapeutic effect
Correct Answer: B
